Millions of healthy older people with no history of heart attack or stroke take low-dose aspirin in the hope it will reduce their risk and prolong good health.
But a new Australian-led study has found that’s not the case.
The study of more than 19,000 healthy people aged over 70 found taking 100 milligrams of aspirin a day didn’t prolong their life or significantly reduce the risk of a first heart attack or stroke.
Lead researcher Professor John McNeil from Monash University said the results of the seven-year study should prompt people who take aspirin — when they have no medical reason for doing so — to reconsider whether it is a good idea.
“We found there was no evidence that aspirin did healthy people any good in terms of living longer, remaining free of disability for longer, or preventing cardiovascular disease,” he said.
And researchers found taking low doses of aspirin each day had potentially serious side effects.
The study, published in the New England Journal of Medicine, found aspirin increased the risk of serious bleeding, a well-known side effect of aspirin.
“That’s an issue in the elderly when people’s blood vessels are a bit more fragile,” Professor McNeil said.
The results of the study only relate to healthy older people aged 70 and above and not to people taking aspirin on medical advice, such as those who have had a heart attack or stroke.
Researchers also looked at whether taking aspirin affected the likelihood of developing dementia, but found little difference between those who took aspirin and those who took a placebo.
The Heart Foundation does not recommend that people who do not have coronary heart disease take daily aspirin.
“People aged over 45 with no known coronary heart disease will benefit most from a healthy lifestyle and seeing their doctor for risk assessments such as blood pressure, cholesterol and sugar levels,” a spokesperson for the Heart Foundation said.








